XML 32 R17.htm IDEA: XBRL DOCUMENT v3.23.1
Derivative Instruments
12 Months Ended
Mar. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments Derivative Instruments
As of March 31, 2023, and 2022, the Company has no outstanding derivative contracts, however, settled derivative contracts with notional values are as follows:
Years Ended March 31,
20232022
Designated Derivative Contracts
$96,345 $110,430 
Non-Designated Derivative Contracts
31,044 38,659 
Total$127,389 $149,089 

The following table summarizes the effect of Designated Derivative Contracts and the related income tax effects of unrealized gains or losses recorded in the consolidated statements of comprehensive income for changes in AOCL:
Years Ended March 31,
202320222021
Gain (Loss) recorded in Other comprehensive income$1,504 $4,161 $(1,223)
Reclassifications from Accumulated other comprehensive loss into net sales(1,504)(4,161)1,223 
Total$ $ $ 

The following table summarizes the effect of Non-Designated Derivative Contracts recorded in the consolidated statements of comprehensive income:
Years Ended March 31,
202320222021
Gain recorded in SG&A expenses$1,518 $611 $267 

Subsequent to March 31, 2023, through May 11, 2023, the Company entered into no Non-Designated Derivative Contracts, but did enter into Designated Derivative Contracts with notional values totaling $127,512, respectively, which are expected to mature over the next 12 months. As of May 11, 2023, the Company’s outstanding hedging contracts were held by an aggregate of three counterparties.